Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Studies from F. Mori et al in the area of cancer gene therapy described
April 1st, 2009
"A genetic vaccine platform based on DNA electroporation (DNA-EP) and adenovirus ( Ad) was used to generate immune response against human carcinoembryonic antigen (CEA) and antitumor effects in murine models with spontaneous tumors arising in an orthotopic location. CEA transgenic ( CEA," scientists in Pomezia, Italy report. "Tg) mice treated with the carcinogen 1,2-dimethylhydrazine developed CEA-overexpressing tumors that resembled human sporadic colorectal cancer. APC1638N/CEA hybrid mice, generated by crossing mice carrying the adenomatous polyposis coli (Apc1638N) gene mutation with CEA. Tg mice, are representative of human familial polyposis and develop polyps...
Source: Vaccine Weekly (2009-04-01)
|
